MUC5AC and airway hyperresponsiveness: The current study supports the hypothesis that extended therapy with LABA monotherapy worsens airways hyperresponsiveness, possibly by upregulating either aspects of the inflammatory response or mucin containing cells and exacerbating distal airway closure thus, providing a potential explanation for the rare severe adverse events associated with LABA mono-therapy in asthmatic patients [10,11].